School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Alexandre Orthwein

  • Department of Radiation Oncology
    Assistant Professor
  • alexandre.orthwein@emory.edu
Head shot of Alexandre Orthwein

Overview

Alexandre Orthwein, MSc, PhD, is Assistant Professor in the Department of Radiation Oncology at Emory University School of Medicine in 2022.

Prior to joining Emory, Dr. Orthwein was an Assistant Professor in the Gerald Bronfman Department of Oncology at McGill University and a Principal Investigator at the Segal Cancer Centre within the Lady Davis Institute for Medical Research at the Jewish General Hospital, where he held the Canada Research Chair in genome stability and hematological malignancies.

Education

Dr. Orthwein obtained his MSC and PhD from the Department of Microbiology and Immunology at the University of Montreal. There, he developed a strong interest in B-cell biology and hematological malignancies by studying a critical mutagenic enzyme called Activation Induced Deaminase in the laboratory of Dr. Javier M. Di Noia at the IRCM in Montreal, Canada.
He subsequently joined the laboratory of Dr. Daniel Durocher at the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada for his postdoctoral training. There, he investigated the interplay between the cell cycle and the signaling/repair of DNA double-strand breaks, the most cytotoxic DNA lesions. In 2014, he became the recipient of the Young Canadian Cell Biologist of the Year awarded by the Canadian Society for Molecular Biosciences.

Research

As cancer biologist and molecular immunologist, Dr. Orthwein is primarily interested in understanding:

(i) how DNA repair pathways are regulated in different physiological contexts, including antibody diversification during B-cell development;
(ii) how their dysregulation can lead to different pathologies, such as cancer and immunodeficiency syndromes;
(iii) how these pathways influence the response to radio- and chemotherapies and the risk of relapse/resistance, particularly for hematological cancers.

His research team uses cutting-edge technologies including genome editing technologies, proteomics and single-cell transcriptomic approaches to tackle these complex and significant knowledge gaps.

Academic Appointment

  • Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine

Education

Degrees

  • PhD from University of Montreal
  • MSc from University of Montreal

Research

Publications

  • The role of tungsten in modulating DNA double-strand break repair and class switch recombination.
    Toxicol Appl Pharmacol Volume: 500 Page(s): 117392
    07/01/2025 Authors: Bakadlag R; Chou H; Guilbert C; Luo VM; Orthwein A; Mann KK
  • Combination radiation and PD-L1 enhance tumor control by stimulating CD8+PD-1+TCF-1+T cells in the tumor-draining lymph node.
    Nat Commun Volume: 16 Page(s): 3522
    04/14/2025 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • Retraction Note: A mechanism for the suppression of homologous recombination in G1 cells.
    Nature Volume: 638 Page(s): 844
    02/01/2025 Authors: Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G
  • Editorial Expression of Concern: 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.
    Nature Volume: 638 Page(s): E34
    02/01/2025 Authors: Fradet-Turcotte A; Canny MD; Escribano-Daz C; Orthwein A; Leung CCY; Huang H; Landry M-C; Kitevski-LeBlanc J; Noordermeer SM; Sicheri F
  • Retraction.
    Science Volume: 387 Page(s): 147
    01/10/2025 Authors: Orthwein A; Fradet-Turcotte A; Noordermeer SM; Canny MD; Brun CM; Strecker J; Escribano-Diaz C; Durocher D
  • The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGF Signaling.
    Cancer Res Volume: 84 Page(s): 3743 - 3760
    11/15/2024 Authors: Heath J; Mirabelli C; Annis MG; Sabourin V; Hebert S; Findlay S; Kim H; Witcher M; Kleinman CL; Siegel PM
  • The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia.
    Blood Adv Volume: 8 Page(s): 5315 - 5329
    10/22/2024 Authors: Jankovic M; Poon WWL; Gonzales-Losada C; Vazquez GG; Sharif-Askari B; Ding Y; Craplet-Desombre C; Ilie A; Shi J; Wang Y
  • An E3 ubiquitin ligase localization screen uncovers DTX2 as a novel ADP-ribosylation-dependent regulator of DNA double-strand break repair.
    J Biol Chem Volume: 300 Page(s): 107545
    08/01/2024 Authors: Djerir B; Marois I; Dubois J-C; Findlay S; Morin T; Senoussi I; Cappadocia L; Orthwein A; Marchal A
  • Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.
    Res Sq
    03/06/2024 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the -Subunit Gng2.
    Mol Cell Biol Volume: 44 Page(s): 1 - 16
    01/01/2024 Authors: Luo VM; Shen C; Worme S; Bhagrath A; Simo-Cheyou E; Findlay S; Hbert S; Wai Lam Poon W; Aryanpour Z; Zhang T
  • FIRRM cooperates with FIGNL1 to promote RAD51 disassembly during DNA repair.
    Sci Adv Volume: 9 Page(s): eadf4082
    08/09/2023 Authors: Pinedo-Carpio E; Dessapt J; Beneyton A; Sacre L; Brub M-A; Villot R; Lavoie EG; Coulombe Y; Blondeau A; Boulais J
  • The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma.
    Blood Adv Volume: 7 Page(s): 3485 - 3500
    07/25/2023 Authors: Findlay S; Nair R; Merrill RA; Kaiser Z; Cajelot A; Aryanpour Z; Heath J; St-Louis C; Papadopoli D; Topisirovic I
  • B cell-specific knockout of AID protects against atherosclerosis.
    Sci Rep Volume: 13 Page(s): 8723
    05/30/2023 Authors: Ebrahimian T; Dierick F; Ta V; Kotsiopriftis M; O'Connor Miranda J; Mann KK; Orthwein A; Lehoux S
  • EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
    J Exp Clin Cancer Res Volume: 41 Page(s): 340
    12/09/2022 Authors: Fooks K; Galicia-Vazquez G; Gife V; Schcolnik-Cabrera A; Nouhi Z; Poon WWL; Luo V; Rys RN; Aloyz R; Orthwein A
  • Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability.
    PLoS Genet Volume: 18 Page(s): e1010495
    11/01/2022 Authors: Simo Cheyou E; Boni J; Boulais J; Pinedo-Carpio E; Malina A; Sherill-Rofe D; Luo VM; Goncalves C; Bagci H; Maters A
  • In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies.
    Blood Adv Volume: 6 Page(s): 5072 - 5084
    09/13/2022 Authors: Mercier FE; Shi J; Sykes DB; Oki T; Jankovic M; Man CH; Kfoury YS; Miller E; He S; Zhu A
  • Multi-omics data integration analysis identifies the spliceosome as a key regulator of DNA double-strand break repair.
    NAR Cancer Volume: 4 Page(s): zcac013
    06/01/2022 Authors: Sherill-Rofe D; Raban O; Findlay S; Rahat D; Unterman I; Samiei A; Yasmeen A; Kaiser Z; Kuasne H; Park M
  • Nearly all multiple-case breast cancer families with HRD tumors are detected by clinical gene panels
    Volume: 30 Page(s): 376 - 376
    04/01/2022 Authors: Matis TS; Zayed N; Labraki B; de la Durantaye M; Matis TA; Hamel N; Atayan A; Rivera B; Tabach Y; Tonin PN
  • A decade of RAD51C and RAD51D germline variants in cancer.
    Hum Mutat Volume: 43 Page(s): 285 - 298
    03/01/2022 Authors: Boni J; Idani A; Roca C; Feliubadal L; Tomiak E; Weber E; Foulkes WD; Orthwein A; El Haffaf Z; Lazaro C
  • Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance.
    Autophagy Volume: 18 Page(s): 540 - 558
    03/01/2022 Authors: Dahabieh MS; Huang F; Goncalves C; Flores Gonzlez RE; Prabhu S; Bolt A; Di Pietro E; Khoury E; Heath J; Xu ZY
  • POGZ promotes homology-directed DNA repair in an HP1-dependent manner.
    EMBO Rep Volume: 23 Page(s): e51041
    01/05/2022 Authors: Heath J; Cheyou ES; Findlay S; Luo VM; Carpio EP; Lee J; Djerir B; Chen X; Morin T; Lebeau B
  • GENOME- WIDE CRISPR SCREENING IDENTIFIES THE E3 UBIQUITIN LIGASE HERC1 AS A MODULATOR OF THE RESPONSE TO NUCLEOSIDE ANALOGS IN ACUTE MYELOID LEUKEMIA
    Volume: 111 Page(s): S97 - S97
    01/01/2022 Authors: Jankovic M; Poon WWL; Vazquez GG; Orthwein A; Mercier F
  • GENOME- WIDE CRISPR SCREENING IDENTIFIES THE MITOCHONDRIAL PYRUVATE CARRIER AS A MODULATOR OF BORTEZOMIB IN MULTIPLE MYELOMA
    Volume: 111 Page(s): S123 - S123
    01/01/2022 Authors: Orthwein A; Findlay S
  • Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families.
    NPJ Breast Cancer Volume: 7 Page(s): 109
    08/25/2021 Authors: Matis TS; Zayed N; Labraki B; de Ladurantaye M; Matis TA; Camacho Valenzuela J; Hamel N; Atayan A; Rivera B; Tabach Y
  • Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline CHEK2 variant.
    Cold Spring Harb Mol Case Stud Volume: 7
    06/01/2021 Authors: Bazinet A; Heath J; Chong A-S; Simo-Cheyou ER; Worme S; Rivera Polo B; Foulkes WD; Caplan S; Johnson NA; Orthwein A
  • FHL2 Is Essential for Spleen T Cell-Dependent B Cell Activation and Antibody Response.
    Immunohorizons Volume: 4 Page(s): 259 - 273
    05/20/2020 Authors: Ebrahimian T; Dierick F; Simon D; Heidari M; Orthwein A; Mann KK; Lehoux S
  • A Functional Assay to Assess Toxicity During Murine B Cell Development In Vitro.
    Curr Protoc Toxicol Volume: 83 Page(s): e91
    03/01/2020 Authors: Guilbert C; Chou H; Bolt AM; Wu TH; Luo VM; Orthwein A; Mann KK
  • OTUB1 is an essential regulator of B-cell development
    Volume: 49 Page(s): 322 - 322
    10/01/2019 Authors: Luo V; Orthwein A
  • Mapping global and local coevolution across 600 species to identify novel homologous recombination repair genes.
    Genome Res Volume: 29 Page(s): 439 - 448
    03/01/2019 Authors: Sherill-Rofe D; Rahat D; Findlay S; Mellul A; Guberman I; Braun M; Bloch I; Lalezari A; Samiei A; Sadreyev R
  • A functionally null RAD51D missense mutation is strongly associated with ovarian carcinoma
    Volume: 26 Page(s): 597 - 598
    10/01/2018 Authors: Rivera B; Di Iorio M; Frankum J; Nadaf J; Fahiminiya S; Arcand S; Burk D; Grapton D; Tomiak E; Hastings V
  • SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.
    EMBO J Volume: 37
    09/14/2018 Authors: Findlay S; Heath J; Luo VM; Malina A; Morin T; Coulombe Y; Djerir B; Li Z; Samiei A; Simo-Cheyou E
  • Genetic interaction between two insulin-dependent diabetes susceptibility loci, Idd2 and Idd13, in determining immunoregulatory DN T cell proportion.
    Immunogenetics Volume: 70 Page(s): 495 - 509
    08/01/2018 Authors: Collin R; Doyon K; Mullins-Dansereau V; Karam M; Chabot-Roy G; Hillhouse EE; Orthwein A; Lesage S
  • GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1.
    Nat Commun Volume: 9 Page(s): 1418
    04/12/2018 Authors: Vadnais C; Chen R; Fraszczak J; Yu Z; Boulais J; Pinder J; Frank D; Khandanpour C; Hbert J; Dellaire G
  • Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency.
    Nat Biotechnol Volume: 36 Page(s): 95 - 102
    01/01/2018 Authors: Canny MD; Moatti N; Wan LCK; Fradet-Turcotte A; Krasner D; Mateos-Gomez PA; Zimmermann M; Orthwein A; Juang Y-C; Zhang W
  • A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.
    Nat Genet Volume: 49 Page(s): 1476 - 1486
    10/01/2017 Authors: Polak P; Kim J; Braunstein LZ; Karlic R; Haradhavala NJ; Tiao G; Rosebrock D; Livitz D; Kbler K; Mouw KW
  • Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.
    Cancer Res Volume: 77 Page(s): 4517 - 4529
    08/15/2017 Authors: Rivera B; Di Iorio M; Frankum J; Nadaf J; Fahiminiya S; Arcand SL; Burk DL; Grapton D; Tomiak E; Hastings V
  • A functionally null RAD51D missense mutation is strongly associated with ovarian carcinoma
    Volume: 77
    07/01/2017 Authors: Rivera B; Di Iorio MR; Frankum J; Nadaf J; Fahiminiya S; Arcand SL; Burk D; Grapton D; Tomiak E; Hastings V
  • Four-And-A-Half LIM Domain Protein 2 Plays a Critical Role in Spleen T-Cell Dependent Antibody Response
    Volume: 37
    05/01/2017 Authors: Ebrahimian T; Simon D; Dierick F; Heidari M; Orthwein A; Mann KK; Lehoux S
  • CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair.
    Sci Adv Volume: 3 Page(s): e1601898
    05/01/2017 Authors: Hilmi K; Jangal M; Marques M; Zhao T; Saad A; Zhang C; Luo VM; Syme A; Rejon C; Yu Z
  • CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Curr Gene Ther Volume: 17 Page(s): 263 - 274
    01/01/2017 Authors: Salsman J; Masson J-Y; Orthwein A; Dellaire G
  • BRCA2 functions: from DNA repair to replication fork stabilization.
    Endocr Relat Cancer Volume: 23 Page(s): T1 - T17
    10/01/2016 Authors: Fradet-Turcotte A; Sitz J; Grapton D; Orthwein A
  • HELB Is a Feedback Inhibitor of DNA End Resection.
    Mol Cell Volume: 61 Page(s): 405 - 418
    02/04/2016 Authors: Tk J; Xu G; Adhikary H; Young JTF; Gallo D; Escribano-Daz C; Krietsch J; Orthwein A; Munro M; Sol W
  • A mechanism for the suppression of homologous recombination in G1 cells.
    Nature Volume: 528 Page(s): 422 - 426
    12/17/2015 Authors: Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G
  • HSP90 inhibitors decrease AID levels and activity in mice and in human cells.
    Eur J Immunol Volume: 45 Page(s): 2365 - 2376
    08/01/2015 Authors: Montamat-Sicotte D; Litzler LC; Abreu C; Safavi S; Zahn A; Orthwein A; Mschen M; Oppezzo P; Muoz DP; Di Noia JM
  • MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection.
    Nature Volume: 521 Page(s): 537 - 540
    05/28/2015 Authors: Boersma V; Moatti N; Segura-Bayona S; Peuscher MH; van der Torre J; Wevers BA; Orthwein A; Durocher D; Jacobs JJL
  • Abstract IA12: Regulation of the RNF168-dependent response to DNA double-strand breaks
    Volume: 74
    12/01/2014 Authors: Orthwein A; Durocher D
  • Mitotic inhibition of the DNA double-strand break response preserves genomic integrity
    Volume: 25
    12/01/2014 Authors: Orthwein A; Fradet-Turcotte A; Noordermeer S; Canny M; Brun C; Strecker J; Escribano-Diaz C; Durocher D
  • RETRACTED: Mitosis inhibits DNA double-strand break repair to guard against telomere fusions.
    Science Volume: 344 Page(s): 189 - 193
    04/11/2014 Authors: Orthwein A; Fradet-Turcotte A; Noordermeer SM; Canny MD; Brun CM; Strecker J; Escribano-Diaz C; Durocher D
  • 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.
    Nature Volume: 499 Page(s): 50 - 54
    07/04/2013 Authors: Fradet-Turcotte A; Canny MD; Escribano-Daz C; Orthwein A; Leung CCY; Huang H; Landry M-C; Kitevski-LeBlanc J; Noordermeer SM; Sicheri F
  • A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice.
    Mol Cell Volume: 49 Page(s): 872 - 883
    03/07/2013 Authors: Escribano-Daz C; Orthwein A; Fradet-Turcotte A; Xing M; Young JTF; Tk J; Cook MA; Rosebrock AP; Munro M; Canny MD
  • Activation induced deaminase: how much and where?
    Semin Immunol Volume: 24 Page(s): 246 - 254
    08/01/2012 Authors: Orthwein A; Di Noia JM
  • Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1.
    EMBO J Volume: 31 Page(s): 679 - 691
    02/01/2012 Authors: Orthwein A; Zahn A; Methot SP; Godin D; Conticello SG; Terada K; Di Noia JM
  • Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90.
    J Exp Med Volume: 207 Page(s): 2751 - 2765
    11/22/2010 Authors: Orthwein A; Patenaude A-M; Affar EB; Lamarre A; Young JC; Di Noia JM
  • Active nuclear import and cytoplasmic retention of activation-induced deaminase.
    Nat Struct Mol Biol Volume: 16 Page(s): 517 - 527
    05/01/2009 Authors: Patenaude A-M; Orthwein A; Hu Y; Campo VA; Kavli B; Buschiazzo A; Di Noia JM
  • Molecular Characteristic of Variant and Classic Hairy Cell Leukemia.
    Volume: 112 Page(s): 389 - 389
    11/16/2008 Authors: Arons E; Suntum T; Sunshine J; Orthwein A; Margulies I; Stetler-Stevenson M; Kreitman R
  • Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.
    J Virol Volume: 81 Page(s): 7476 - 7490
    07/01/2007 Authors: Finzi A; Orthwein A; Mercier J; Cohen EA
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements